Sunscreen products: Rationale for use, formulation development and regulatory considerations

被引:73
|
作者
Geoffrey, Kiriiri [1 ]
Mwangi, A. N. [1 ]
Maru, S. M. [1 ]
机构
[1] Univ Nairobi, Sch Pharm, Dept Pharmaceut & Pharm Practice, POB 19676-00202, Nairobi, Kenya
关键词
Sunscreens; Photoprotection; Ultraviolet rays; UVA; UVB; Sun protection factor (SPF); Water resistance; Minimum erythemal dose (MED); SKIN-CANCER; ULTRAVIOLET-RADIATION; PROTECTION FACTORS; SUN EXPOSURE; LIGHT; PREVENTION; EFFICACY;
D O I
10.1016/j.jsps.2019.08.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The association of sunrays with skin damage have been known since medieval times. The description of the electromagnetic spectrum facilitated the identification of the ultraviolet light spectrum as being responsible for skin damage resulting from prolonged skin exposure. Sunscreens have been used since ancient civilizations with various measures to limit exposure to sun exposure being employed. Awareness of the risks associated with sunrays has been increasing in the last century, and as a result, the science, technologies, and formulation have advanced significantly. The use of sunscreen products continues rising as government health agencies seek to contain increasing cases of UV induced melanomas. Recreational sunbathing and artificial tanning have increased the risk for these diseases significantly. This review article sought to expound the scientific basis of sunscreen use, the classification, formulation, quality control and regulation across the different countries around the world. The literature review was conducted on Google scholar, PubMed, SCOPUS, Cochrane, BMJ, SCIELO among others. (C) 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
引用
收藏
页码:1009 / 1018
页数:10
相关论文
共 50 条
  • [31] USE OF SUNSCREEN AGENTS NO LONGER CONFINED TO SUN CARE PRODUCTS
    BUTTS, JT
    SOAP COSMETICS CHEMICAL SPECIALTIES, 1984, 60 (10): : 32 - &
  • [32] Formulation of Pickering emulsions for the development of surfactant-free sunscreen creams
    Bordes, Claire
    Bolzinger, Marie-Alexandrine
    El Achak, Myriam
    Pirot, Fabrice
    Arquier, Delphine
    Agusti, Geraldine
    Chevalier, Yves
    INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, 2021, 43 (04) : 432 - 445
  • [33] Formulation Considerations for Autologous T Cell Drug Products
    van der Walle, Christopher F.
    Godbert, Sonya
    Saito, Gabriele
    Azhari, Zein
    PHARMACEUTICS, 2021, 13 (08)
  • [34] Development of sunscreen products containing passion fruit seed extract
    Lourith, Nattaya
    Kanlayavattanakul, Mayuree
    Chingunpitak, Jiraporn
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 53 (01)
  • [35] Use of bacteriocins in food: Regulatory considerations
    Fields, FO
    JOURNAL OF FOOD PROTECTION, 1996, : 72 - 77
  • [36] Topical bioequivalence: Experimental and regulatory considerations following formulation complexity
    Miranda, Margarida
    Veloso, Claudia
    Brown, Marc
    Pais, Alberto A. C. C.
    Cardoso, Catarina
    Vitorino, Carla
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2022, 620
  • [37] Bioavailability Enhancement Strategies: Basics, Formulation Approaches and Regulatory Considerations
    Beg, Sarwar
    Swain, Suryakanta
    Rizwan, Md.
    Irfanuddin, Md.
    Malini, D. Shobha
    CURRENT DRUG DELIVERY, 2011, 8 (06) : 691 - 702
  • [38] Regulatory considerations in the development of encapsulated cells
    Chapekar, MS
    BIOARTIFICIAL ORGANS: SCIENCE, MEDICINE, AND TECHNOLOGY, 1997, 831 : 10 - 12
  • [39] Regulatory considerations for Campylobacter vaccine development
    Kopecko, DJ
    JOURNAL OF INFECTIOUS DISEASES, 1997, 176 : S189 - S191
  • [40] Regulatory considerations in the design, development and quality of monoclonal antibodies and related products for the diagnosis and treatment of cancer
    Shapiro, Marjorie A.
    FRONTIERS IN ONCOLOGY, 2024, 14